Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of octreotide on urine output during orthotopic liver transplantation
IRCT2012120411662N1Phase 4Completed
- Sponsor
- Vice Chancellor for Research of Tehran University of Medical Sciences
- Start
- Sep 2011
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4 trial of octreotide in Cirrhosis and hepatic disease, sponsored by Vice Chancellor for Research of Tehran University of Medical Sciences. Primary endpoint: Urine output during orthotopic liver transplantation. Started Sep 2011; status: completed.
02
Drugs
octreotide
03
Conditions
Cirrhosishepatic disease
Beyond the preview
Go deeper on IRCT2012120411662N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2012120411662N1.